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Review Article on Socioeconomic Disparities in the Treatment of Thoracic Malignancies
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Background: To review and discuss the current literature regarding socio-economic and racial disparities
in the treatment of early-stage non-small cell lung cancer (NSCLC).
Background: Lung cancer is the most lethal solid organ malignancy in the United States, with the secondhighest incidence of new malignances for both men and women. While overall survival for lung cancer is
improving, significant socioeconomic and racial disparities in outcomes for lung cancer persist.
Methods: Narrative review of peer reviewed literature synthesizing findings retrieved from searches of
computerized databases, primary article reference lists, authoritative texts and expert options.
Results: The current incidence of lung cancer appears to be similar between White and Black patients.
However, Black patients are substantially less likely to receive curative intent surgery. Mitigation strategies
do exist to narrow this inequity. Lower socioeconomic status (SES) is associated with a higher incidence of
lung cancer, lower utilization of surgery and poorer outcomes after surgery.
Conclusions: Race and SES remain closely linked to outcomes in lung cancer. Outcomes are still worse
when controlling for stage and specifically, in early-stage disease, surgical therapy is consistently underused
in Black patients and patients of low SES.
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Introduction
Lung cancer is the most lethal solid organ malignancy
in the United with more than 150,000 deaths in 2018
and accounting for approximately 25% of all cancer
deaths (1). While, the majority of lung cancer patients
present with metastatic disease, a third of patients present
with locoregional disease and approximately fifteen percent
present with localized disease only (1). Standard of care
treatment for early-stage non-small cell lung cancer
(NSCLC) is anatomic lung resection with a multi-station
lymph node dissection. Survival after resection of early-
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stage non-small cell lung cancer (ESNSCLC) can be greater
than 85% at five years (2). For patients who are not surgical
candidates, stereotactic ablative radiosurgery (SABR)
provides high local control rates and improves survival,
although surgical resection remains the standard of care (3).
While overall survival for lung cancer is increasing,
significant disparities in outcomes for lung cancer persist.
Socioeconomic and racial inequities are pervasive in lung
cancer outcomes (4,5). Specifically, patients from lower
socioeconomic status (SES) and of Black race have less
favorable outcomes compared to those of high SES and
non-Hispanic White race (6-9). As these two issues are
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inextricably linked, both will be covered in this narrative
review. We present the following article in accordance with
the Narrative Review Reporting Checklist (available at:
http://dx.doi.org/10.21037/jtd-20-3181).
Methods
A literature search was conducted via PubMed and Medline
databases using the following key words: Lung cancer, racial
disparities, socioeconomic, race, Black and lung cancer
screening. The inclusion criteria were (I) peer-reviewed
academic journals published in English and between the
years 1990 and 2020. (II) Research that focused on racial
and socio-economic disparities in lung cancer treatment.
(III) Research regarding racial and socio-economic
differences in tobacco consumption. Manual searches of
the reference lists of primary articles found from initial
searches were also conducted. Editorials, commentaries and
conference abstracts were excluded from the analysis. The
impactful and salient articles in the author’s opinion were
reviewed and synthesized in this review.
Discussion
Racial inequities
Background
The incidence of lung cancer is currently similar between
White Americans and Black Americans, with approximately
55 per 100,000 people (1). The rates for all new lung cancer
cases have consistently decreased over the last two decades,
mainly due to reduced rates of tobacco use. Historically,
black men had the highest incidence of lung cancer of any
racial and gender group (10). Some have suggested this
was due to the high rates of smoking in black men in the
southern United States and menthol cigarette smoking in
the Black population (11). However, these differences have
narrowed in recent years (12,13). Black patients still present
with more advanced disease than their White counterparts
(14,15). When accounting for the stage at presentation
and other factors, Black patients still have lower five-year
survival for local disease than their White counterparts.
There is also data to suggest that Black patients receiving
surgical resection are more likely to die during perioperative
period (16).
There are many questions as to the origin of this
disparity, as curative lung resection is a major operation
with requisite pre-operative functional status and lung
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function requirements. It has been postulated that disparity
in early-stage cancer is due to poor preoperative functional
status or lung function, though these assertions have limited
support as the complete explanation for the inequity (17).
Other more complex issues such as access to care, medical
mistrust, disinformation, disparity in testing, disparity in
lung function assessment and physician communication all
likely play a part (18,19).
Utilization of surgery
Early reports demonstrate that Black patients were less
likely to undergo curative intent surgical therapy (20).
Bach et al. used the Surveillance, Epidemiology and End
Results (SEER) Medicare database, to analyze patients
with Stage I or Stage II NSCLC over the age of 65 for
overall survival and the utilization of surgery. The five-year
survival for Black and White patients who underwent lung
cancer resection was similar at 39% and 43%, respectively.
The five-year survival for patients who did not receive
surgery was similar at 4% and 5%. However, 77% of White
patients underwent surgery, while 64% of Black patients
received surgery. Using hierarchical analyses controlling
for age, stage, income, and comorbidities, Black race was
still associated with receiving less surgery than White race.
Thus, they concluded that race as a sole factor associated
with the lower utilization of surgery and the disparity in
overall survival between Black and White patients.
A more recent study by Dalwadi et al. used the SEER
database in a more modern sample to look at the utilization
of surgery by race (21). They analyzed patients aged 60
and over between 2004 and 2012 with Stage I and Stage II
NSCLC. They report that Black patients received surgery
at a 58 percent rate compared to 67 percent of White
patients and had a two-year lung cancer-specific survival
of 76 percent compared to 79 percent in White patients.
When adjusting for stage, age, and treatment, the difference
in survival was no longer significant.
Soneji et al. analyzed surgery utilization rates in earlystage cancer patients by race (9). Black patients were not
recommended surgery at a 34% rate, while White and
Asian patients had surgery not recommended at a rate
of 24%. Overall survival for Black patients, including all
causes, was lower for Black patients. When controlling
for the receipt of surgery in patients with early-stage lung
cancer, there was still worse overall survival for Black
patients. This was found to be due to higher rates of death
from other competing causes, including heart and kidney
disease.
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Our group recently chose to investigate this topic using
the National Cancer Database (NCDB). We analyzed
the utilization of local therapy (surgery and radiation)
therapy (4). We found a similar trend with White patients
receiving significantly more surgery than Black patients in
our sample from 2004 to 2015 (67% vs. 60%, P<0.001).
We also found that the rates of surgery for both Black and
White patients improved dramatically from 2004 to 2015,
with White patients increasing from 57% to 65% and Black
patients increasing from 44% to 62%. When adjusting for
the receipt of surgery, the survival difference between Black
and White patients disappeared. In the most recent sample,
Black patients who received surgery had improved survival
compared to White patients, likely due to their younger age
at diagnosis.
Mitigation
As the studies above have clearly shown, there is a
persistent inequity in the utilization of surgery between
Black and White patients. Some groups have looked
to determine the mechanism of the development of
these inequities and how to mitigate them. Cykert et al.
interviewed patients with newly diagnosed resectable
lung cancer and asked them what factors influenced their
decision to undergo or not undergo surgical resection (22).
They found the same disparity in the utilization of
surgery in Black patients as others found historically. Both
White and Black patients’ poor perception of patientphysician communication and negative perception of
one-year survival after surgery were associated with
deferring surgical therapy. Black patients with two or more
comorbidities and no regular source of healthcare were
very likely to defer surgery (22).
Multiple studies have shown that Black patients have
complex views on the receipt of surgery. Studies have shown
that poor physician-patient communication, misconceptions
about cancer biology, and low trust all result in Black
patients not choosing surgery when it is offered (23,24).
A multi-site interventional study looked at eliminating
the gap in utilizing surgery by using a three-pronged
approach (25). The intervention was a real-time warning
in the electronic medical record, feedback to the providers
about the outcomes of early-stage lung cancer by race, and
the utilization of a nurse navigator to manage the warning
system. The intervention raised the level of local therapy
for both races and equalized them from pre-intervention
levels (25).
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Socioeconomic disparities
Background
Socioeconomic factors are broadly defined as a combination
of income, education, area of residence, and insurance
status. The Black population in America experiences a
significantly lower SES than the White population in
America. Specifically, Black people have lower levels of
wealth, education and are more likely than White patients
to live in urban areas (26-28). These inequities stem from
the history of slavery, Jim Crow, and systemic racism in
America.
Socioeconomic disparities in outcomes for all cancers
have been widely noted (29). Specifically, for lung
cancer, it has been demonstrated that the incidence of
lung cancer increases as patients have lower SES (8,30).
Based on race, patients of lower SES present with more
advanced disease than those with higher status. Low SES
is tied to tobacco use and is partially thought to be the
driving force behind the high incidence of cancer in this
group. However, environmental factors and exposures to
other known carcinogens are likely to contribute (31,32).
Some reports indicate that poor SES make it 70%
more likely for men and 50% more likely for women to
develop lung cancer (31).
Detection and management
Recently the National Lung Cancer Screening Trial and
the NELSON trial in Europe have demonstrated improved
lung cancer-specific survival for high-risk patients screened
with CT scans (33,34). This benefit is most pronounced
in women and racial minority patients. As in other areas in
cancer care, disparities in screening exist based on SES (35).
Specifically, uninsured patients are 72% less likely to get
screened than insured patients. For patients with detected
cancers, SES plays a role in their early management.
Population-level data indicates that higher SES is associated
with a higher likelihood of receiving the following indicated
interventions: a brain MRI, lung resection, palliative
radiation, and adjuvant chemotherapy. Lower SES is also
closely associated with not receiving NCCN guidelineconcordant care (36,37).
For ESNSCLC, the standard of care is anatomic lung
resection with systematic lymph node sampling. Lower SES
has not been associated with higher rates of refusal when
surgery is offered (38). However, lower income and lower
SES was associated with not receiving surgery or any local
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therapy in several multivariable analyzes using large datasets
(4,39). These inequities in these studies persisted even when
controlling for race. A recent meta-analysis of 46 studies
showed that lower SES had an OR of 0.68 as compared to
the highest SES for the receipt of surgery (40).
Outcomes
Further compounding the inequities of SES and lung
cancer are the outcomes of lower SES patients after surgery.
First, even though patients with lower SES are diagnosed
at a younger age, they are far more likely to suffer
lung cancer mortality even when adjusting for stage at
diagnosis (8). Even after pulmonary resection, lower SES
was still associated with lower overall survival (41). Lower
SES, specifically income and insurance status, on analysis
of the National Cancer Database is associated with hospital
readmission after surgical resection and readmission after
surgical resection has been associated with decreased longterm survival (42,43). For patients who are found to have
locoregional disease, it has been shown they are less likely
to receive chemotherapy in the adjuvant setting, which
improves survival (41,44,45).
Conclusions
Race and SES remain closely linked to outcomes in lung
cancer. It is likely that there many contributing factors
as to why black patients are less likely to receive surgical
therapy including racism, medical mistrust, suboptimal
communication and nihilism. Though SES appears to the
tied to the overall incidence of cancer, the incidence of
lung cancer currently does not correlate with race alone.
There seems to be a bias for patients to present with
more advanced disease for both low SES and Black race.
However, outcomes are still worse when controlling for
stage. Specifically, in early-stage disease, surgical therapy is
consistently underused in Black patients and patients of low
SES. Our review does have limitations since we may not
have included all the relevant published literature due to
the limited electronic databases examined and the language
criterion. However, our review attempts to summarize the
empirical evidence concerning the disparities in the delivery
of standard of care lung cancer treatment to patients of
both low SES and Black race, and serves as a basis for
future efforts to understand and attempt to remedy these
disparities.
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